Inhibrx Biosciences, Inc.(INBX)内部人交易:高管与董事近期交易
过去 18 个月,共有 12 位内部人为 Inhibrx Biosciences, Inc.(INBX)报告了 49 笔 Form 4 交易(最近一笔 2026-10-14)。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-14 | Lappe Mark | Chief Executive Officer | 买入 | 2,470 | $207,655 |
| 2026-10-14 | Lappe Mark | Chief Executive Officer | 买入 | 2,470 | $209,948 |
| 2026-10-14 | Lappe Mark | Chief Executive Officer | 买入 | 100 | $8,576 |
| 2026-10-14 | Lappe Mark | Chief Executive Officer | 买入 | 2,449 | $205,889 |
| 2026-10-14 | Lappe Mark | Chief Executive Officer | 买入 | 2,451 | $208,333 |
| 2026-10-14 | Lappe Mark | Chief Executive Officer | 买入 | 100 | $8,576 |
| 2026-09-28 | Lappe Mark | Chief Executive Officer | 买入 | 3,000 | $305,100 |
| 2026-09-28 | Lappe Mark | Chief Executive Officer | 买入 | 2,176 | $216,730 |
| 2026-09-28 | Lappe Mark | Chief Executive Officer | 买入 | 1,500 | $148,320 |
| 2026-09-28 | Lappe Mark | Chief Executive Officer | 买入 | 3,324 | $328,644 |
| 2026-09-23 | Kayyem Jon Faiz | 董事 | 买入 | 5,000 | $500,000 |
| 2026-09-17 | Kayyem Jon Faiz | 董事 | 买入 | 5,000 | $500,000 |
| 2026-09-15 | MANHARD KIMBERLY | 董事 | 卖出 | 500 | $55,130 |
| 2026-09-15 | MANHARD KIMBERLY | 董事 | 卖出 | 500 | $52,525 |
| 2026-09-15 | MANHARD KIMBERLY | 董事 | 卖出 | 500 | $55,890 |
| 2026-09-10 | MANHARD KIMBERLY | 董事 | 卖出 | 500 | $57,570 |
| 2026-09-10 | MANHARD KIMBERLY | 董事 | 卖出 | 500 | $57,900 |
| 2026-09-08 | Lappe Mark | Chief Executive Officer | 买入 | 9,681 | $1.1M |
| 2026-09-08 | Kayyem Jon Faiz | 董事 | 买入 | 5,000 | $567,600 |
| 2026-09-08 | FORSYTH DOUGLAS | 董事 | 买入 | 2,500 | $286,625 |
| 2026-09-08 | Lappe Mark | Chief Executive Officer | 买入 | 5,895 | $585,315 |
| 2026-09-08 | Lappe Mark | Chief Executive Officer | 买入 | 6,605 | $664,727 |
| 2026-09-08 | Lappe Mark | Chief Executive Officer | 买入 | 1,100 | $117,832 |
| 2026-09-08 | Lappe Mark | Chief Executive Officer | 买入 | 500 | $54,120 |
| 2026-09-08 | Lappe Mark | Chief Executive Officer | 买入 | 1,219 | $136,382 |
来源:SEC Form 4 申报文件 · 截至 2026-10-14